Extra-Ordinary General Meeting (hereinafter referred to as 'EGM') of the Members of Covidh Technologies Limited will be held on Thursday, 2nd day of April, 2026 at 12:00 P.M., through ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Covidh Technologies Ltd has called an EGM on April 2, 2026 at 12:00 PM via video conferencing, with remote e-voting from March 30 to April 1, 2026 (cut-off March 26, 2026). The key item is a special resolution to change the company's name from 'Covidh Technologies Limited' to 'iSERA Lifesciences Limited' to reflect a strategic pivot from the technology sector into the medical and life sciences business. Four additional ordinary resolutions seek shareholder approval to appoint four directors for five-year terms effective April 2, 2026: Mr. Dhairyasheel Vasantrao Yadav and Mr. Nandkumar Subhash Kadam as Executive Directors, and Mr. Pratap Dadasaheb Deshmukh and Ms. Ritu Dhanraj Garad as Non-Executive, Non-Independent Directors. The existing BSE listing (scrip code 534920) continues, and contracts, liabilities, and legal proceedings under the old name will remain valid. The change is subject to Registrar of Companies approval and SEBI Regulation 45 compliance.
Shareholders will be asked to approve a significant corporate rebranding that signals a business shift from technology to life sciences/healthcare, which could affect the stock's narrative and investor interest. Approval of the name change is subject to regulatory clearances, and once effective the stock will trade under the new identity on BSE. Appointment of two new Executive Directors and two Non-Executive Directors reshapes the leadership team aligned with the new business direction.